Autolus Therapeutics ROA 2018-2020 | AUTL

Current and historical return on assets (ROA) values for Autolus Therapeutics (AUTL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Autolus Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.14B $0.32B -44.09%
2020-06-30 $-0.13B $0.31B -41.01%
2020-03-31 $-0.13B $0.34B -38.68%
2019-12-31 $-0.12B $0.30B -40.03%
2019-09-30 $-0.10B $0.32B -34.94%
2019-06-30 $-0.09B $0.35B -31.31%
2019-03-31 $-0.07B $0.26B -34.89%
2018-12-31 $-0.06B $0.25B -44.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.471B $0.003B
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.559B 10.73
Amgen (AMGN) United States $142.917B 14.94
CSL (CSLLY) Australia $94.680B 0.00
Gilead Sciences (GILD) United States $79.386B 10.56
Vertex Pharmaceuticals (VRTX) United States $58.652B 27.27
Regeneron Pharmaceuticals (REGN) United States $55.266B 19.60
Illumina (ILMN) United States $54.947B 75.57
Moderna (MRNA) United States $51.304B 0.00
Biogen (BIIB) United States $42.447B 7.54
Alexion Pharmaceuticals (ALXN) United States $34.293B 13.66
Seagen (SGEN) United States $33.601B 88.45
BeiGene (BGNE) Cayman Islands $31.460B 0.00
Genmab (GMAB) Denmark $29.102B 34.42
Genmab (GNMSF) Denmark $28.182B 6.49
BioNTech SE (BNTX) Germany $22.986B 0.00
Exact Sciences (EXAS) United States $21.957B 0.00
Incyte (INCY) United States $19.832B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.328B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
Horizon Therapeutics Public (HZNP) Ireland $17.374B 24.83
Guardant Health (GH) United States $15.925B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.062B 99.96
CRISPR Therapeutics AG (CRSP) Switzerland $14.233B 0.00
Bio-Techne Corp (TECH) United States $13.425B 85.85
ARGENX SE-ADR (ARGX) Netherlands $13.219B 0.00
QIAGEN (QGEN) Netherlands $12.116B 27.28
Repligen (RGEN) United States $11.338B 160.80
Mirati Therapeutics (MRTX) United States $10.784B 0.00
Fate Therapeutics (FATE) United States $9.910B 0.00
Adaptive Biotechnologies (ADPT) United States $8.903B 0.00
Twist Bioscience (TWST) United States $8.817B 0.00
Denali Therapeutics (DNLI) United States $8.758B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.531B 0.00
Ascendis Pharma (ASND) Denmark $8.436B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.422B 0.00
Novavax (NVAX) United States $8.112B 0.00
Acceleron Pharma (XLRN) United States $7.603B 0.00
Exelixis (EXEL) United States $7.361B 49.43
Sarepta Therapeutics (SRPT) United States $7.127B 0.00
Beam Therapeutics (BEAM) United States $6.552B 0.00
Galapagos (GLPG) Belgium $6.542B 0.00
Halozyme Therapeutics (HALO) United States $6.412B 296.44
SWEDISH ORP BIO (BIOVF) Sweden $5.964B 17.44
NeoGenomics (NEO) United States $5.860B 1759.33
Amicus Therapeutics (FOLD) United States $5.690B 0.00
Emergent Biosolutions (EBS) United States $5.633B 18.49
Blueprint Medicines (BPMC) United States $5.628B 18.63
Certara (CERT) United States $5.559B 0.00
Vir Biotechnology (VIR) United States $5.008B 0.00
Eidos Therapeutics (EIDX) United States $4.916B 0.00
Intellia Therapeutics (NTLA) United States $4.838B 0.00
Editas Medicine (EDIT) United States $4.746B 0.00
Arena Pharmaceuticals (ARNA) United States $4.682B 0.00
China Biologic Products (CBPO) China $4.658B 30.19
Arvinas (ARVN) United States $4.386B 0.00
Legend Biotech (LEGN) United States $3.938B 0.00
Reata Pharmaceuticals (RETA) United States $3.819B 0.00
Insmed (INSM) United States $3.692B 0.00
MorphoSys AG (MOR) Germany $3.630B 131.38
Alkermes (ALKS) Ireland $3.560B 34.95
Bluebird Bio (BLUE) United States $3.354B 0.00
Global Blood Therapeutics (GBT) United States $3.085B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.851B 0.00
I-Mab (IMAB) China $2.826B 0.00
Intra-Cellular Therapies (ITCI) United States $2.708B 0.00
Zymeworks (ZYME) Canada $2.506B 0.00
Sorrento Therapeutics (SRNE) United States $2.498B 0.00
Arcus Biosciences (RCUS) United States $2.401B 0.00
Amarin (AMRN) Ireland $2.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.242B 0.00
Seres Therapeutics (MCRB) United States $2.234B 0.00
Sangamo Therapeutics (SGMO) United States $2.228B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Myriad Genetics (MYGN) United States $2.009B 0.00
Ligand Pharmaceuticals (LGND) United States $1.983B 51.39
Viela Bio (VIE) United States $1.979B 0.00
Scholar Rock Holding (SRRK) United States $1.932B 0.00
Revance Therapeutics (RVNC) United States $1.906B 0.00
NGM Biopharmaceuticals (NGM) United States $1.883B 0.00
NantKwest (NK) United States $1.873B 0.00
PHARMA MAR SA (PHMMF) Spain $1.857B 0.00
REGENXBIO (RGNX) United States $1.808B 0.00
Genetron Holdings (GTH) China $1.775B 0.00
Vericel (VCEL) United States $1.772B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.769B 0.00
UniQure (QURE) Netherlands $1.670B 0.00
Inovio Pharmaceuticals (INO) United States $1.636B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.544B 0.00
Heska (HSKA) United States $1.516B 0.00
Codexis (CDXS) United States $1.500B 0.00
Zealand Pharma (ZEAL) Denmark $1.497B 0.00
Castle Biosciences (CSTL) United States $1.494B 0.00
Precigen (PGEN) United States $1.486B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.462B 0.00
Mersana Therapeutics (MRSN) United States $1.445B 0.00
Travere Therapeutics (TVTX) United States $1.415B 0.00
Cytokineticsorporated (CYTK) United States $1.342B 0.00
Alector (ALEC) United States $1.337B 0.00
Cellectis S.A (CLLS) France $1.313B 0.00
Bionano Genomics (BNGO) United States $1.291B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Coherus BioSciences (CHRS) United States $1.277B 8.44
Antibe Therapeutics (ATBPF) Canada $1.231B 0.00
Frequency Therapeutics (FREQ) United States $1.209B 0.00
Epizyme (EPZM) United States $1.191B 0.00
Mesoblast (MESO) Australia $1.142B 0.00
Northwest Biotherapeutics (NWBO) United States $1.112B 0.00
Adverum Biotechnologies (ADVM) United States $1.108B 0.00
Sutro Biopharma (STRO) United States $1.043B 0.00
Athenex (ATNX) United States $1.037B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.974B 0.00
MiMedx (MDXG) United States $0.974B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.970B 0.00
Morphic Holding (MORF) United States $0.940B 0.00
Protagonist Therapeutics (PTGX) United States $0.932B 0.00
Pliant Therapeutics (PLRX) United States $0.927B 0.00
Cara Therapeutics (CARA) United States $0.925B 0.00
Pharming Group (PHGUF) Netherlands $0.914B 24.33
Intercept Pharmaceuticals (ICPT) United States $0.906B 0.00
Compugen (CGEN) Israel $0.890B 0.00
Kadmon Holdings (KDMN) United States $0.834B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.833B 0.00
Syros Pharmaceuticals (SYRS) United States $0.792B 0.00
VBI Vaccines (VBIV) United States $0.781B 0.00
Avid Bioservices (CDMO) United States $0.768B 0.00
Curis (CRIS) United States $0.753B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.752B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.751B 38.14
Adaptimmune Therapeutics (ADAP) United Kingdom $0.744B 0.00
MannKind (MNKD) United States $0.730B 0.00
AnaptysBio (ANAB) United States $0.714B 0.00
Celldex Therapeutics (CLDX) United States $0.694B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.689B 0.00
Albireo Pharma (ALBO) United States $0.679B 0.00
Merus (MRUS) Netherlands $0.678B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
Agenus (AGEN) United States $0.637B 0.00
MeiraGTx Holdings (MGTX) United States $0.628B 0.00
DBV Technologies S.A (DBVT) France $0.622B 0.00
Affimed (AFMD) Germany $0.608B 0.00
Precision BioSciences (DTIL) United States $0.593B 0.00
Dynavax Technologies (DVAX) United States $0.565B 0.00
Pandion Therapeutics (PAND) United States $0.564B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.562B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.562B 0.00
Anika Therapeutics (ANIK) United States $0.558B 75.44
Prothena (PRTA) Ireland $0.543B 0.00
Five Prime Therapeutics (FPRX) United States $0.541B 0.00
Geron (GERN) United States $0.512B 0.00
FORTE BIOSCIENC (FBRX) United States $0.509B 0.00
AquaBounty Technologies (AQB) United States $0.495B 0.00
Clovis Oncology (CLVS) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.478B 0.00
Cardiff Oncology (CRDF) United States $0.475B 0.00
Starpharma Holdings (SPHRY) Australia $0.466B 0.00
Amryt Pharma (AMYT) United Kingdom $0.464B 0.00
Spero Therapeutics (SPRO) United States $0.447B 0.00
WAVE Life Sciences (WVE) Singapore $0.445B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.440B 0.00
XOMA (XOMA) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.436B 20.52
Puma Biotechnology (PBYI) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.425B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Verastem (VSTM) United States $0.416B 0.00
AMMO (POWW) United States $0.404B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.10
Selecta Biosciences (SELB) United States $0.384B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.383B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
Athersys (ATHX) United States $0.380B 0.00
CytomX Therapeutics (CTMX) United States $0.367B 0.00
Innate Pharma S.A (IPHA) France $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.353B 0.00
NextCure (NXTC) United States $0.339B 0.00
Trevena (TRVN) United States $0.333B 0.00
Arbutus Biopharma (ABUS) United States $0.332B 0.00
Voyager Therapeutics (VYGR) United States $0.318B 8.17
Fortress Biotech (FBIO) United States $0.316B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.310B 0.00
Kamada (KMDA) Israel $0.310B 14.50
Bellus Health (BLU) Canada $0.291B 0.00
ChromaDex (CDXC) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Aptinyx (APTX) United States $0.261B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Cogent Biosciences (COGT) United States $0.231B 0.00
Checkpoint Therapeutics (CKPT) United States $0.227B 0.00
Eton Pharmaceuticals (ETON) United States $0.220B 0.00
TELA Bio (TELA) United States $0.207B 0.00
Pluristem Therapeutics (PSTI) Israel $0.206B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
Exicure (XCUR) United States $0.202B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Theratechnologies (THTX) Canada $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.195B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.195B 0.00
Clearside Biomedical (CLSD) United States $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
Abeona Therapeutics (ABEO) United States $0.188B 0.00
DiaMedica Therapeutics (DMAC) United States $0.188B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Lumos Pharma (LUMO) United States $0.176B 0.00
Prometic Life Sciences (LMNL) Canada $0.161B 0.00
Idera Pharmaceuticals (IDRA) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Evogene (EVGN) Israel $0.157B 0.00
Oncobiologics (OTLK) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.146B 0.00
Catalyst Biosciences (CBIO) United States $0.144B 0.00
Aptevo Therapeutics (APVO) United States $0.142B 0.00
TRACON Pharmaceuticals (TCON) United States $0.139B 0.00
Prima BioMed (IMMP) Australia $0.135B 0.00
Ecology Coatings (ABVC) United States $0.132B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.125B 259.50
Synlogic (SYBX) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.121B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
Cyclerion Therapeutics (CYCN) United States $0.109B 0.00
Vascular Biogenics (VBLT) Israel $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Aytu Bioscience (AYTU) United States $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.094B 0.00
MiRagen Therapeutics (MGEN) United States $0.090B 0.00
CollPlant Holdings (CLGN) Israel $0.089B 0.00
CytRx (CYTR) United States $0.088B 0.00
Seelos Therapeutics (SEEL) United States $0.086B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 37.50
Adocia (ADOCY) France $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Purple Biotech (PPBT) Israel $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Genetic Technologies (GENE) Australia $0.056B 0.00
Yumanity Therapeutics (YMTX) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Vaccinex (VCNX) United States $0.054B 0.00
Acorda Therapeutics (ACOR) United States $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.052B 0.00
Edesa Biotech (EDSA) Canada $0.051B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Cleveland BioLabs (CBLI) United States $0.047B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Chanticleer Holdings (SONN) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Advaxis (ADXS) United States $0.040B 0.00
AEterna Zentaris (AEZS) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
Spherix (AIKI) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.036B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
Neuralstem (SNCA) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00